Clinical studies recruiting near Fort Smith

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Mercy Hospital Fort Smith · Alliance for Clinical Trials in Oncology · NCT07091617 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · Mercy Clinic Fort Smith Communities · PrECOG, LLC. · NCT06538038 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Mercy Hospital Fort Smith · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Mercy Hospital Fort Smith · Alliance for Clinical Trials in Oncology · NCT06632327 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Mercy Hospital Fort Smith · Alliance for Clinical Trials in Oncology · NCT06876714 GEMINI-NSCLC: NSCLC Biomarker Study
Phase N/A · Mercy Clinic Oncology - Fort Smith · Tempus AI · NCT05236114 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Mercy Hospital Fort Smith · National Cancer Institute (NCI) · NCT04269902 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Mercy Hospital Fort Smith · NRG Oncology · NCT06748222 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Mercy Hospital Fort Smith · Alliance for Clinical Trials in Oncology · NCT04242095 Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
NA · Mercy Hospital Fort Smith · Eastern Cooperative Oncology Group · NCT05108298 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Mercy Hospital Fort Smith · ECOG-ACRIN Cancer Research Group · NCT04566328 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Mercy Hospital Fort Smith · Alliance for Clinical Trials in Oncology · NCT05677490 Galleri® in the Medicare Population.
NA · Mercy Health - Fort Smith · GRAIL, Inc. · NCT05673018 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Mercy Hospital Fort Smith · National Cancer Institute (NCI) · NCT06058377 A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V60
Phase 2 · Mercy Hospital Fort Smith · SWOG Cancer Research Network · NCT04511013 An Internet-based Program to Help Cancer Survivors Manage Pain
NA · Mercy Hospital Fort Smith · Wake Forest University Health Sciences · NCT04462302 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · Mercy Hospital Fort Smith · NRG Oncology · NCT05080673 Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Phase 3 · Mercy Hospital Fort Smith · Children's Oncology Group · NCT06513962 Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · Mercy Hospital Fort Smith · SWOG Cancer Research Network · NCT04205968 Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Phase 3 · Mercy Hospital Fort Smith · Alliance for Clinical Trials in Oncology · NCT05008848 Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Phase 3 · Mercy Hospital Fort Smith · ECOG-ACRIN Cancer Research Group · NCT04423211 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head
Phase 2 · Mercy Hospital Fort Smith · ECOG-ACRIN Cancer Research Group · NCT02734537 Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Phase N/A · Mercy Hospital Fort Smith · ECOG-ACRIN Cancer Research Group · NCT06002828 Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
NA · Mercy Hospital Fort Smith · Alliance for Clinical Trials in Oncology · NCT07283939 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · Mercy Hospital Fort Smith · SWOG Cancer Research Network · NCT03723928 Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Phase 3 · Mercy Hospital Fort Smith · ECOG-ACRIN Cancer Research Group · NCT06475989 Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · Mercy Hospital Fort Smith · National Cancer Institute (NCI) · NCT03866382 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Mercy Hospital Fort Smith · National Cancer Institute (NCI) · NCT04267848 Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Phase 3 · Mercy Hospital Fort Smith · ECOG-ACRIN Cancer Research Group · NCT03937635 Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3 · Mercy Hospital Fort Smith · NRG Oncology · NCT06580314

Look up another city

Look up another condition